AD-223 / Yuhan Corp - LARVOL DELTA

A Study to Evaluate the Efficacy and Safety of AD-223 (clinicaltrials.gov) - P3 | N=502 | Completed | Sponsor: Addpharma Inc. | Active, not recruiting ➔ Completed

Trial completion • Cardiovascular • Hypertension

A Study to Evaluate the Efficacy and Safety of AD-223 (clinicaltrials.gov) - P3 | N=486 | Active, not recruiting | Sponsor: Addpharma Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed • Cardiovascular • Hypertension

A Study to Evaluate the Efficacy and Safety of AD-223 (clinicaltrials.gov) - P3 | N=486 | Recruiting | Sponsor: Addpharma Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Hypertension

A Study to Evaluate the Efficacy and Safety of AD-223 (clinicaltrials.gov) - P3 | N=486 | Not yet recruiting | Sponsor: Addpharma Inc.

Combination therapy • New P3 trial • Cardiovascular • Hypertension